Summary
50 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 55% this fiscal year.
- It bought back its own shares for ¥38.3B in the last fiscal year, 5.7% of its market value.
- Out of every 100 JPY of revenue, 10 JPY is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 14% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 2.9% a year over 5 years. Over the last 3 years it fell by 14% a year. For the next fiscal year analysts expect revenue to grow by 55%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of ¥43.2B.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 4.63%
- Raised in a row
- 2 years
You receive $0.88 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.